Brief: Astria Therapeutics Reports Fourth Quarter And Full Year 2022 Financial Results And Provides A Corporate Update

Astria Therapeutics

22/03/2023 12:13

March 22 (Reuters) - Astria Therapeutics Inc  ATXS.O :
    * ASTRIA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
    * QTRLY NET LOSS PER SHARE BASIC AND DILUTED WAS $0.72
    * LPHA-STAR PHASE 1B/2 TRIAL IN PEOPLE WITH HAE UNDERWAY
WITH
INITIAL PROOF-OF-CONCEPT RESULTS ANTICIPATED MID-2024
    * ENDED 4Q 2022 WITH CASH, CASH EQUIVALENTS, AND SHORT-TERM
INVESTMENTS OF $226M, EXPECTED CASH RUNWAY THROUGH H1 2025

Source text for Eikon:  ID:nBwbLZwf6a 
Further company coverage:  ATXS.O 

 ((Reuters.Briefs@thomsonreuters.com;;))